Related references
Note: Only part of the references are listed.Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis
Veronica Massey et al.
GASTROENTEROLOGY (2021)
Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH
Jinrui Dong et al.
NATURE COMMUNICATIONS (2021)
IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGFβ-mediated activation of dermal fibroblasts
Eleonora Adami et al.
RHEUMATOLOGY (2021)
Redefining IL11 as a regeneration-limiting hepatotoxin and therapeutic target in acetaminophen-induced liver injury
Anissa A. Widjaja et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation
Stuart A. Cook et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Matias A. Avila et al.
GUT (2020)
Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis
Laura Weichselbaum et al.
JOURNAL OF HEPATOLOGY (2020)
Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11
Riley D. Metcalfe et al.
FRONTIERS IN IMMUNOLOGY (2020)
Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients
Sonja Lang et al.
GUT MICROBES (2020)
Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy
Anissa A. Widjaja et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Burden of liver diseases in the world
Sumeet K. Asrani et al.
JOURNAL OF HEPATOLOGY (2019)
Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis
Anissa A. Widjaja et al.
GASTROENTEROLOGY (2019)
Emerging roles for Interleukin-11 in disease
Paul M. Nguyen et al.
GROWTH FACTORS (2019)
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Benjamin Ng et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The Immune System Computes the State of the Body: Crowd Wisdom, Machine Learning, and Immune Cell Reference Repertoires Help Manage Inflammation
Irun R. Cohen et al.
FRONTIERS IN IMMUNOLOGY (2019)
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
JOURNAL OF HEPATOLOGY (2018)
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
Loris Riccardo Lopetuso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Max G. Griswold et al.
LANCET (2018)
Alcoholic liver disease
Helmut K. Seitz et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
IL-11 is a crucial determinant of cardiovascular fibrosis
Sebastian Schafer et al.
NATURE (2017)
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia
David W. Crabb et al.
GASTROENTEROLOGY (2016)
Alcoholic Hepatitis: Translational Approaches to Develop Targeted Therapies
Pranoti Mandrekar et al.
HEPATOLOGY (2016)
IL-6 pathway in the liver: From physiopathology to therapy
Dirk Schmidt-Arras et al.
JOURNAL OF HEPATOLOGY (2016)
Alcoholic liver disease: mechanisms of injury and targeted treatment
Alexandre Louvet et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
IL-11 Attenuates Liver Ischemia/Reperfusion Injury (IRI) through STAT3 Signaling Pathway in Mice
Miao Zhu et al.
PLOS ONE (2015)
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
Adeline Bertola et al.
NATURE PROTOCOLS (2013)
Interleukin-11 Links Oxidative Stress and Compensatory Proliferation
Takashi Nishina et al.
SCIENCE SIGNALING (2012)
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Bin Gao et al.
GASTROENTEROLOGY (2011)
A protective role of interleukin 11 on hepatic injury in acute endotoxemia
K Maeshima et al.
SHOCK (2004)
A pilot study of interleukin-11 in subjects with chronic hepatitis C and advanced liver disease nonresponsive to antiviral therapy
EJ Lawitz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Protective effect of rhIL-11 in a murine model of acetaminophen-induced hepatotoxicity
WL Trepicchio et al.
TOXICOLOGIC PATHOLOGY (2001)
Mechanisms of disease: Cytokines in alcoholic and nonalcoholic steatohepatitis.
H Tilg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease
A Parlesak et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
